These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8395334)

  • 1. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.
    Bargetzi MJ; Lantz M; Smith CG; Torti FM; Olsson I; Eisenberg SP; Starnes HF
    Cancer Res; 1993 Sep; 53(17):4010-3. PubMed ID: 8395334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist.
    Latini R; Bianchi M; Correale E; Dinarello CA; Fantuzzi G; Fresco C; Maggioni AP; Mengozzi M; Romano S; Shapiro L
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):1-6. PubMed ID: 7511719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
    J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 and interleukin-1 receptor antagonist.
    Dinarello CA
    Nutrition; 1995; 11(5 Suppl):492-4. PubMed ID: 8748206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.
    Tilg H; Shapiro L; Atkins MB; Dinarello CA; Mier JW
    J Immunol; 1993 Sep; 151(6):3299-307. PubMed ID: 8397255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
    Powell JJ; Fearon KC; Siriwardena AK; Ross JA
    Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.
    Tilg H; Shapiro L; Vannier E; Poutsiaka DD; Trehu E; Atkins MB; Dinarello CA; Mier JW
    J Immunol; 1994 Mar; 152(6):3189-98. PubMed ID: 8144913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.
    Steensberg A; Fischer CP; Keller C; Møller K; Pedersen BK
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E433-7. PubMed ID: 12857678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.